Development and Applica0on of Real- Time Clinical Predic0ve Models
|
|
- Rosemary Preston
- 5 years ago
- Views:
Transcription
1 Development and Applica0on of Real- Time Clinical Predic0ve Models Ruben Amarasingham, MD, MBA Associate Professor, UT Southwestern Medical Center AHRQ- funded R24 UT Southwestern Center for Pa?ent- Centered Outcomes Research CEO, Parkland Center for Clinical Innova?on Date: Monday, December 1, 2015 Time: 12:00 1:00pm
2 Objec?ves Background: Predic?on and the Prac?ce of Medicine A Taxonomy for Predic?on and Decision Support Applica?on to Readmissions Further Considera?ons Q&A 2
3 What We Do in Medicine: Predic?on 1. What does this pa?ent have? 2. What will this pa?ent develop? 3. What will be the effect of a given therapy? 3
4 Predic?on in the Context of Modern Medicine Staggering increase in medical informa?on Increasing volume of decisions at mul?ple levels High fragmenta?on of care Increasing capacity for error 4
5 Glimmers of a New Age in Medicine Massive data capture Real-?me precision monitoring Vast computa?onal power Natural Language Processing Machine Learning 5
6 A Modified Taxonomy Term Predic?on Rule Decision Rule Decision Analysis Decision Support Prac?ce Guidelines e- Health Predic?ve Analysis Defini0on Provides diagnos?c or prognos?c probabili?es; does not recommend decision. Predic?on rule sufficiently validated to recommend decisions Quan?fies value of specified outcomes from published literature; health policy Designed to prevent errors when implemen?ng decisions already made Address several issues for pa?ents with a par?cular syndrome; ocen consensus based Technologies or socware systems that can autonomously employ and some?mes reengineer, modify, or update clinical risk predic?on models Reilly BM et al. Annals of Internal Medicine 2006;144: Amarasingham R et al. Health Affairs
7 Clinical Applica?on of Predic?ve Analy?cs for Different Condi?ons and?meframe Hours 30 days 90 days Years Cardio- Pulmonary Arrest Sepsis Pa?ent Safety Event Surgical Complica?on Readmissions All- Cause AMI CHF PNA HIV Cirrhosis 7 Short- Term Diabe?c Complica?ons Chronic Kidney Disease Preventable DM Admissions
8 Predic?ng 30- Day Readmission in Heart Failure in Real- Time Heart failure readmissions are common, costly, and many are poten?ally preventable EMR- based readmission models are promising: Can tap many domains of risk Produce ac?onable intelligence usable in real-?me New domains of interest include: Socio- demographics, mental health/substance abuse, social disadvantage 8
9 Conceptual Model and Program Theory 9
10 Modeling HF Severity of Illness Model: Age, Albumin, T bili, CK, Crea?nine, Na, BUN, pco2, WBC, TN- I, Glucose, INR, BNP, ph, Temp, Pulse, Diastolic BP, Systolic BP (deriva?on=273, 034; valida?on=629,400) Tabak et al, Medical Care,
11 Odds Ra?os for 30 Day Readmission for Final Model Variables Variable 11 Multivariate OR (95% CI) Tabak Mortality Score (composite) 1.52 ( ) Single 1.44 ( ) Male 1.37 ( ) Number of Home Address Changes 1.13 ( ) Medicare 1.59 ( ) Residence in low SES census tract 1.38 ( ) History of documented cocaine use 1.78 ( ) History of missed clinic visit 1.35 ( ) Used a health system pharmacy 0.72 ( ) Number of prior inpatient admissions 1.17 ( ) Presentation time (day or night) 1.38 ( ) History of Depression or Anxiety 1.44 ( )
12 Performance of Electronic Heart Failure Model (N=1372, C- Stat 0.72) Derivation Samples Validation Samples Very Low Low Intermediate High Very High Predicted Readmission Risk Category 12 Amarasingham et al, Medical Care, 2010
13 From Predic?on to Ac?on: HF Interven?on Challenges & Solu?ons Iden?fy HF pa?ents in the first 24 hrs of admission Ocen no defini?ve admission diagnosis (SOB, edema, cough) Natural language processing to flag cases Too many pa?ents & too expensive to try to do everything on everyone Iden?fy those at highest risk to get enhanced suite of inpa?ent & outpa?ent interven?ons Provide electronic surveillance, coordina?on, & tracking of interven?on processes of care & outcomes 13
14 Readmission Preven?on Interven?on Workflow Admission Discharge 30 Days 90 Days 24 hours 7 days ID Risk List Orders Inpatient Intervention 5 5 Outpatient Intervention Evaluation & Improvement 6 Electronic Medical Record Real- Time HL7 based interface EMR applica0on 14
15 Interven?on Results: 26% Rela?ve Reduc?on in Odds of Readmission Results Demonstrated: Concentrated care management efforts on ¼ of the pa?ents 26% rela?ve reduc?on in odds of readmission Absolute reduc?on of 5 readmissions per 100 index admissions Saved hospital $1 million 15
16 Compara?ve Effec?veness of Different Models for Predic?ng Readmissions 1. EMR- based v. administra?ve claims models 2. Develop & validate an all- cause, mul?- condi?on model 3. First- day v. full- stay models 4. Mul?- condi?on generic v. disease- specific models 5. Customizing models to individual hospitals, data systems, pa?ent popula?ons 16
17 Develop and Validate an All- Cause, Real- Time, Mul?- condi?on model 40 Derivation cohort Validation cohort group 1 group 2 group 3 group 4 group 5 Predicted Risk Category Amarasingham et al. Under Review,
18 EMR All Cause model versus CMS and LACE models 18
19 All- Cause 30- Day Readmission Model Full Hospital Stay versus First Day (n=16430) Predicted Risk, % C- sta?s?c (95% CI) Lowest Highest All- cause full- stay Deriva0on cohort ( ) 4 37 Valida0on cohort ( ) 4 37 All- cause 24- hour ( ) 6 32 Other models: LACE* ( ) 6 28 HOSPITAL model ( ) 7 27 CMS HWR ( )
20 Other Considera?ons 1. Interven?ons for highest risk pa?ents 2. Considering clinical vs. social risk 3. Explana?on vs. Predic?on 4. Non- health care data sources 5. Changing EMR data models 6. Changing clinical interven?ons 7. Changing popula?ons 20
21 Larger Complexi?es of Predic?ve Modeling in Healthcare 21
22 Clinical Applica?on of Predic?ve Analy?cs for Different Condi?ons and?meframe Hours 30 days 90 days Years Cardio- Pulmonary Arrest Sepsis Pa?ent Safety Event Surgical Complica?on Readmissions All- Cause AMI CHF PNA HIV Cirrhosis 22 Short- Term Diabe?c Complica?ons Chronic Kidney Disease Preventable DM Admissions
23 Conclusions Predic?ve analy?cs are a promising way to help improve?meliness, safety and quality in health care; CHF model and interven?on are an example of successful implementa?on of predic?ve analy?cs in real- world setng; All Cause, Mul?- Condi?on Readmission Model has poten?al to have more significance for applica?on; Many challenges remain in methodology, applica?on and policy for electronic predic?ve analysis to thrive. 23
24 Ques?ons Contact Informa0on: Ruben Amarasingham 24
Learning Objec1ves. Study Design Considera1ons in Clinical Pharmacy
9/28/15 Study Design Considera1ons in Clinical Pharmacy Ludmila Bakhireva, MD, PhD, MPH Pree Sarangarm, PharmD, BCPS Learning Objec1ves Describe the features, advantages and disadvantages of the observa1onal
More informationLearning Objec1ves. Study Design Strategies. Cohort Studies 9/28/15
9/28/15 Learning Objec1ves Describe the features, advantages and disadvantages of the observa1onal study designs Explain why the overall study design is important when evalua1ng studies & applying their
More informationBiosta's'cs Board Review. Parul Chaudhri, DO Family Medicine Faculty Development Fellow, UPMC St Margaret March 5, 2016
Biosta's'cs Board Review Parul Chaudhri, DO Family Medicine Faculty Development Fellow, UPMC St Margaret March 5, 2016 Review key biosta's'cs concepts Understand 2 X 2 tables Objec'ves By the end of this
More informationEconomic outcomes: Method for implementa5on
Economic outcomes: Method for implementa5on Philippe Beutels Centre for Health Economics Research & Modelling Infec
More informationCommon Data Elements: Making the Mass of NIH Measures More Useful
Common Data Elements WG Common Data Elements: Making the Mass of NIH Measures More Useful Jerry Sheehan Assistant Director for Policy Development Na?onal Library of Medicine Gene/c Alliance Webinar Series
More informationWelcome! Pragmatic Clinical Studies. David Hickam, MD, MPH Program Director Clinical Effectiveness Research. David Hickam, MD, MPH
Pragmatic Clinical Studies David Hickam, MD, MPH Program Director Clinical Effec2veness Research June 23, 2015 Welcome! David Hickam, MD, MPH Program Director Clinical Effectiveness Research 2 In this
More informationA review of approaches to identifying patient phenotype cohorts using electronic health records
A review of approaches to identifying patient phenotype cohorts using electronic health records Shivade, Raghavan, Fosler-Lussier, Embi, Elhadad, Johnson, Lai Chaitanya Shivade JAMIA Journal Club March
More informationAddressing the Challenge of Medica3on Adherence. Jan Berger MD, MJ President and CEO Health Intelligence Partners
Addressing the Challenge of Medica3on Adherence Jan Berger MD, MJ President and CEO Health Intelligence Partners Drugs Have Become the Mainstay of Healthcare Treatment America s Other Drug Problem Non-adherence
More informationFrailty in Geriatric Trauma Pa1ents
Division of Trauma, Burn, Surgical Critical Care, & Emergency General Surgery Frailty in Geriatric Trauma Pa1ents Zara Cooper, MD, MSc, FACS Elizabeth Bryant, MPH Disclosures NIA R01AG044518 NCI R35CA197730
More informationIdentifying Engineering, Clinical and Patient's Metrics for Evaluating and Quantifying Performance of Brain- Machine Interface Systems
Identifying Engineering, Clinical and Patient's Metrics for Evaluating and Quantifying Performance of Brain- Machine Interface Systems Jose Pepe L. Contreras-Vidal, Ph.D. Department of Electrical & Computer
More informationDepartment of Emergency Office of Research. Shannon McNabb, MA, MPH Clinical Research Manager January 2017
Department of Emergency Medicine Office of Research Shannon McNabb, MA, MPH Clinical Research Manager January 2017 EM Study Tracking System UPDATED ON: 12/5/2016 TOTAL 68 Grants Submitted, Award Pending
More informationChronic Kidney Disease
Chronic Kidney Disease Management Issues in the Hospital and Beyond in pre dialysis CKD pa;ents Brian Wolfe, MD Assistant Professor of Medicine University of Colorado Denver, Hospital Medicine Sec;on Case:
More informationFindings from the At Home / Chez Soi Demonstration Project in Canada. Paula Goering and Catharine Hume May 2, 2013
Findings from the At Home / Chez Soi Demonstration Project in Canada Paula Goering and Catharine Hume May 2, 2013 Outline for today Overview of Project Design Na8onal level findings re one year outcomes
More informationA large database study in the general population in England
Time-dependent markers of comorbidity severity and change are associated with increased risk of mortality in heart failure: A large database study in the general population in England Claire A. Rushton,
More informationFor more information about how to cite these materials visit
Author(s): Rajesh Mangrulkar, M.D., 2013 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Non-commercial Share Alike 3.0 License: http://creativecommons.org/licenses/by-nc-sa/3.0/
More informationEngage and Empower Pa.ents with Interac.ve Technology. Northeast NAHAM Regional Conference Pa.ent Access: GeBng It Right Upfront October 22-23, 2012
Engage and Empower Pa.ents with Interac.ve Technology Northeast NAHAM Regional Conference Pa.ent Access: GeBng It Right Upfront October 22-23, 2012 NAHAM - Pa.ent Access Services 2 Pa%ent Access Services
More information2015 Na(onal Medicaid and CHIP Oral Health Symposium
MSDA Medicaid CHIP State Dental Association 2015 Na(onal Medicaid and CHIP Oral Health Symposium Session # 9 Primary Care Physician Integra(on into Dental Program An(cipatory Guidance, Screening & Care
More informationPublic Health / Public Works Introduc6on, reitera6on + Lessons 1-2. Pioneer Winter IDH 3034, IDH 4007
Public Health / Public Works Introduc6on, reitera6on + Lessons 1-2 Pioneer Winter IDH 3034, IDH 4007 What s the purpose of this class? Learning Objec6ves Understand the principles of public health, epidemiology,
More informationHeart Failure - Large Market Opportuni4es for New Biomarkers
Heart Failure - Large Market Opportuni4es for New Biomarkers Integra4on of Market and Clinical Research Previously Presented Publicly Predominantly in 2011 Heart Failure Pa4ent Sta4s4cs Show Large Unmet
More informationDesign, Conduct and Analysis of Pragma?c Clinical Trials in Pallia?ve Care Research
Design, Conduct and Analysis of Pragma?c Clinical Trials in Pallia?ve Care Research Sco$ D. Halpern, M.D., Ph.D. Associate Professor of Medicine, Epidemiology, and Medical Ethics & Health Policy Director,
More informationLeveraging the HSX Clinical Data Repository to Improve Behavioral Health Care:
Leveraging the HSX Clinical Data Repository to Improve Behavioral Health Care: Insights from the Montgomery County Hospital Partnership HEALTHSHARE EXCHANGE BOARD OF TRUSTEES ANNUAL MEETING NOVEMBER 14,
More information3/31/2015. Designing Clinical Research Studies: So You Want to Be an
Designing Clinical Research Studies: So You Want to Be an Inves@gator Andrea Bonny, MD Ellen Lançon Connor, MD On behalf Of The NASPAG Research CommiPee Objec@ves Learn to design a clinical research project
More informationPerspec'vas Psicologicas en el Cuidado de la Diabetes
Perspec'vas Psicologicas en el Cuidado de la Diabetes Antonio E. Puente University of North Carolina Wilmington Universidad de la Ciudad de Juarez 09.20.13 Health Sta's'cs: 2010 (The Economist, 12.12.09)
More informationPragma&c Clinical Trials
Pragma&c Clinical Trials Susanne May, PhD Associate Professor Department of Biosta&s&cs, School of Public Health, University of Washington Preliminaries PLEASE ask ques&ons at any &me REALLY good clinical
More informationMental Health, Substance Abuse & Primary Care: Bridging Gaps in Access
1 Mental Health, Substance Abuse & Primary Care: Bridging Gaps in Access Christopher Carroll, Director, Health Care Financing and Systems Integration Substance Abuse and Mental Health Services Administration
More informationDesigning and Delivering ACT Interven2ons for Individuals with Medical Condi2ons:
ACBS Symposium World Con 12 Designing and Delivering ACT Interven2ons for Individuals with Medical Condi2ons: Transdiagnos2c principles and key change processes Megan Oser, PhD Vanessa Alvarez, MA Gabe
More informationSession 13 Objec+ves MSDA Na+onal Medicaid and CHIP Oral Health Symposium June 24 th 26 th, 2012
2012 MSDA Na+onal Medicaid and CHIP Oral Health Symposium June 24 th 26 th, 2012 Session 13 Dental Quality Alliance Update Krishna Aravamudhan, BDS, MS (DQA) Martha Dellapena (MSDA) Session 13 Objec+ves
More informationIndependence Well- being and Choice 2005, Our health, our care, our say 2006, Strong and Prosperous 2006
Medicines Op+misa+on Outcome focused approach to safe and effec+ve use of medicines that takes into account the pa+ent s values, percep+on and experience of taking their medicines Important Outcomes for
More informationOncology Care Model Overview
Oncology Care Model Overview Centers for Medicare & Medicaid Services Innova3on Center (CMMI) September 2017 Innova3on at CMS Center for Medicare & Medicaid Innova3on (Innova3on Center) Established by
More informationA Trial Implementa.on of a High Density Health Informa.on Exchange Standard: Are We Ready for Coordinated Care in High Impact Condi.ons?
A Trial Implementa.on of a High Density Health Informa.on Exchange Standard: Are We Ready for Coordinated Care in High Impact Condi.ons? Michael Hogarth, MD, FACP CMIO, Athena Breast Health Network Professor,
More informationConsidera*ons when undergoing personal genotyping
Considera*ons when undergoing personal genotyping Kelly Ormond, MS, CGC Louanne Hudgins, MD, FACMG January 19, 2011 GENE 210 Disclosures and introduc*ons Professor Ormond provided paid consulta*on for
More informationFall & Injury Preven/on: Demen/a + Hospitals = The Perfect Storm
Fall & Injury Preven/on: Demen/a + Hospitals = The Perfect Storm Tiffany E. Shubert, PhD, PT Carolina Geriatric Educa/on Consor/um UNC School of Medicine June 11, 2014 Acknowledgements This work was supported
More informationManaging the U+liza+on of CT and MR Studies in an Era of Precer+fica+on
Managing the U+liza+on of CT and MR Studies in an Era of Precer+fica+on Steven E. Seltzer, M.D. Department of Radiology Brigham and Women s Hospital Harvard Medical School Boston, MA COI Disclosure - Partners
More informationEvidence- based Catheter Associated Urinary Tract Infec8on CAUTI Preven8on. Effec%ve CAUTI Preven%on Saves Lives, Prevents Harm, and Reduces Costs
Evidence- based Catheter Associated Urinary Tract Infec8on CAUTI Preven8on Effec%ve CAUTI Preven%on Saves Lives, Prevents Harm, and Reduces Costs Maureen Dailey, PhD, RN, CWOCN CMS Leadership to Reduce
More informationBlue Cross Blue Shield of Michigan Building a Statewide PCMH Program: Design, Evalua>on Methods, and Results
Blue Cross Blue Shield of Michigan Building a Statewide PCMH Program: Design, Evalua>on Methods, and Results Margaret Mason, MHSA Michael Paus6an, PhD, MS Amanda Markovitz, MPH 1 Overview of BCBSM Serving
More informationPrédire la récupéra1on rénale. Michaël DARMON Réanima1on polyvalente CHU de Saint- E1enne
Prédire la récupéra1on rénale Michaël DARMON Réanima1on polyvalente CHU de Saint- E1enne Non- specific AKI in the ICU Lameire et al. Lancet 2005 The classical view Intense renal vasoconstric1on r= - 0.82;
More informationIllinois Accountability Technical Advisory Committee (TAC) Academic Growth for Accountability
Illinois Accountability Technical Advisory Committee (TAC) Academic December 18-19, 2017 Questions for the TAC What model features and characteris@cs are most important? What evidence should be collected
More informationCaring for cancer patients with comorbidity. Chair: Associate Professor Diana Sarfa3
Caring for cancer patients with comorbidity Chair: Associate Professor Diana Sarfa3 Why do we care? Comorbidity: is common among cancer pa3ents. has a major impact on pa3ents. has a major impact on health
More informationHow does a heart surgeon prevent a heart a>ack?
How does a heart surgeon prevent a heart a>ack? Michael Richman M.D., F.A.C.S. CEO and Director, The Center for Cholesterol Management Los Angeles, California www.lipidcenter.com Heart disease: #1 killer
More informationDecision Support. HAP 752 Advanced Health Informa6on Systems. Janusz Wojtusiak, PhD George Mason University Spring 2014
Decision Support HAP 752 Advanced Health Informa6on Systems Janusz Wojtusiak, PhD George Mason University Spring 2014 Evidence does not make decisions, people do. - Haynes, Devereaux, GuyaQ (BMJ 2002)
More informationBig Data Science and Analytics in Health and Biomedicine
References Big Data Science and Analytics in Health and Biomedicine William Hersh, MD, FACP, FACMI Professor and Chair Department of Medical Informatics & Clinical Epidemiology Oregon Health & Science
More informationReducing Readmissions and Improving Outcomes at OhioHealth Mansfield Hospital:
Reducing Readmissions and Improving Outcomes at OhioHealth Mansfield Hospital: Eugenio H. Zabaleta, Ph.D. Clinical Chemist OhioHealth Mansfield Hospital Reducing Readmissions and Improving Outcomes at
More informationPreven'ng AKI. Lessons from Contrast-associated AKI It s all about urine output
Preven'ng AKI Lessons from Contrast-associated AKI It s all about urine output CASE A 76 y/o male comes to the ED complaining of substernal crushing chest pain. The pain started a few hours ago while he
More informationPa#ern recogni,on and neuroimaging in psychiatry
Pa#ern recogni,on and neuroimaging in psychiatry Janaina Mourao-Miranda Machine Learning and Neuroimaging Lab Max Planck UCL Centre for Computa=onal Psychiatry and Ageing Research Outline Supervised learning
More informationPsychological outcomes of cri2cal illness for pa2ents and family members. Erin K. Kross, MD Summer Lung Day June 18, 2010
Psychological outcomes of cri2cal illness for pa2ents and family members Erin K. Kross, MD Summer Lung Day June 18, 2010 Outline Overview of psychological outcomes for pa2ents and family members ager cri2cal
More informationMedication Adherence Campaign Target Market Tracking Survey Results National Consumers League October 9, 2015
Medication Adherence Campaign Target Market Tracking Survey Results National Consumers League October 9, 2015 Objectives An ini%al target market survey was launched in May 2011 to serve as a benchmark
More informationUpper Extremity Fractures and Secondary Fall Prevention: Opportunities to Improve Management and Outcomes Across Disciplines.
Upper Extremity Fractures and Secondary Fall Prevention: Opportunities to Improve Management and Outcomes Across Disciplines Chris,ne McDonough, PhD, PT, CEEAA Health Outcomes Unit Department of Health
More informationTackling Tobacco Through Re-engineered Primary Care
2/27/18 Tackling Tobacco Through Re-engineered Primary Care Daren Wu, M.D. Chief Medical Officer Learning Objec>ves Understand the key stumbling blocks that can interfere with tobacco screening and treatment,
More informationAggressive Medical Management with or without Angioplasty and Sten8ng for Symptoma8c Intracranial Atherosclero8c Stenosis: Long Term Results
Aggressive Medical Management with or without Angioplasty and Sten8ng for Symptoma8c Intracranial Atherosclero8c Stenosis: Long Term Results Disclosures Funding by NINDS U01 NS058728 Boston Scien8fic provided
More informationMedical informa.on, flow and building rapid learning cancer knowledge centers
Medical informa.on, flow and building rapid learning cancer knowledge centers Craig Nichols, MD Visi.ng Professor Bri.sh Columbia Cancer Agency Director- Tes.cular Cancer Consor.um LIVESTRONG- Health Informa.on
More informationC-reac've protein-based TB screening
C-reac've protein-based TB screening Advanced TB Diagnos0cs Workshop June 22, 2017 Chris0na Yoon, MD, MPH University of California, San Francisco Systema'c TB screening Recommendations 1-3 Should be done:
More informationUSING EVIDENCE FOR HEMATOLOGY LABORATORY PRACTICE. Alfonso Iorio McMaster University, Canada
USING EVIDENCE FOR HEMATOLOGY LABORATORY PRACTICE Alfonso Iorio McMaster University, Canada Disclosures Financial No relevant rela1onships to disclose Research funding in the field of hemophilia care Intellectual
More informationF. Bochicchio The approach of the INRAP for preven8on and mi8ga8on and the new Direc8ve on BSS. Radon Protec8on Conf. Dresden, 2 3 Dec.
Radon protec8on conference New challenges for the European construc8on and ven8la8on branches of Europe Dresden (Sachsen, Germany) December 2 nd 3 rd 2013 The approach of the Italian Na1onal Radon Ac1on
More informationThe Canadian Landscape of PaAent Reported Outcome and Experience Measures. Santana MJ, MPharm, PhD October 17, 2016, Amsterdam
The Canadian Landscape of PaAent Reported Outcome and Experience Measures Santana MJ, MPharm, PhD October 17, 2016, Amsterdam Canada & Netherlands: The Tulip Legacy Outline Overview -- Na+onal strategy
More informationThe Availability of Homeopathic Medicinal Products (HMPs) in Europe with reference to the Matrix Report
The Availability of Homeopathic Medicinal Products (HMPs) in Europe with reference to the Matrix Report A presenta@on to the European Parliament CAM Interest Group 1 July 2015 By Stephen Gordon General
More informationPreparing Pre-health Professional Students & Advisors for the Mul8ple Mini-Interviews: Advanced Issues
Preparing Pre-health Professional Students & Advisors for the Mul8ple Mini-Interviews: Advanced Issues Robert Klitzman, MD Professor of Psychiatry Director, Bioethics Masters & Online Certificate & Course
More informationHealth Informa.cs. Lecture 9. Samantha Kleinberg
Health Informa.cs Lecture 9 Samantha Kleinberg samantha.kleinberg@stevens.edu Next week: journal club For all papers: read, and prepare to comment on For your paper: Read the ar.cle (+ other references
More informationResolving the PSA testing controversy. Professor Villis Marshall AC Professor Bruce Armstrong AM Professor Mark Frydenberg
Resolving the PSA testing controversy Professor Villis Marshall AC Professor Bruce Armstrong AM Professor Mark Frydenberg Professor Villis Marshall AC Introduc)on Guidelines aim to inform tes)ng for the
More informationDocumenting in the World of ICD-10 Capturing all your CCs and MCCs Crystal Coen, RN, MSN, FNP-BC NPSS Asheville, NC
Documenting in the World of ICD-10 Capturing all your CCs and MCCs Crystal Coen, RN, MSN, FNP-BC 2017 NPSS Asheville, NC Objectives Understand the importance of documenting to the highest specificity Understand
More informationFinding and Using Local Data for Suicide Preven7on
Finding and Using Local Data for Suicide Preven7on January 21 st, 2014 1 Welcome! Please mute your phone or microphone line If you have a ques7on, please type it into the Ques7ons box or raise your hand
More information1/24/15. In pursuit of evidence- based prac8ce. Accessibility of Available Evidence. Today s Purpose BUT FIRST... Levels of Evidence (LOE)
Speeding Up the EBP Process: Using Evidence that is Appraised, Available, and Ready To Go In pursuit of evidence- based prac8ce Clinician s best judgment How do we gain access to available evidence? Cailee
More informationCausal Inference from Complex Observa4onal Data. Samantha Kleinberg
Causal Inference from Complex Observa4onal Data Samantha Kleinberg samantha.kleinberg@stevens.edu Three key points We need causal knowledge Causes are hard to find It s not hopeless! Most striking, society
More informationNQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based)
Last Updated: Version 4.3 NQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE Measure Information Form Collected For: CMS Outcome Measures (Claims Based) Measure Set: CMS Readmission Measures Set
More informationGenetic Tests and Genetic Counseling How to Analyze Your Own Genome
Genetic Tests and Genetic Counseling 02-223 How to Analyze Your Own Genome Genetic Tests for Huntington Disease Hun7ngton Disease Incurable brain disorder that runs in families Movement, cogni7ve, and
More informationHospital Transition Management. Barbara Wood, BSN, MBA
Hospital Transition Management Barbara Wood, BSN, MBA Director, Embedded Care Management Programs OBJECTIVES Improve health care quality for our patients by streamlining care transitions Reduce avoidable
More informationEffec&ve Messaging for Suicide Preven&on:
Effec&ve Messaging for Suicide Preven&on: Anara Guard anara@suicideispreventable.org Lessons from a statewide campaign and from a na&onal framework This morning The Know the Signs statewide social marke&ng
More information2015 Na(onal Medicaid and CHIP Oral Health Symposium. Integra(ng Oral and General Healthcare. Bruce Donoff, DMD, MD. Session #
MSDA Medicaid CHIP State Dental Association 2015 Na(onal Medicaid and CHIP Oral Health Symposium Session # Integra(ng Oral and General Healthcare Bruce Donoff, DMD, MD Washington Marrio4 Wardman Park Tuesday,
More informationCaveats and Recommendations for Use of Operational Electronic Health Record Data for Research and Quality Measurement
Caveats and Recommendations for Use of Operational Electronic Health Record Data for Research and Quality Measurement References William Hersh, MD, FACP, FACMI Diplomate, Clinical Informatics, American
More informationSuicide Care in Systems Framework: National Action Alliance Clinical Care and Intervention Task Force
Suicide Care in Systems Framework: National Action Alliance Clinical Care and Intervention Task Force David A. Jobes, Ph.D., ABPP Professor of Psychology Associate Director of Clinical Training The Catholic
More informationAn Introduc+on to Cancer Care at Kaiser Permanente Northwest. Phoebe E. Harvey, MD Chief, Hematology/Oncology Medical Director, Cancer Service Line
An Introduc+on to Cancer Care at Kaiser Permanente Northwest Phoebe E. Harvey, MD Chief, Hematology/Oncology Medical Director, Cancer Service Line April 16, 2016 Agenda Overview and history of KP Northwest
More informationPopulation Health: The Path from Volume to Value
AZ Rural & Public Health Policy Forum Population Health: The Path from Volume to Value Mark Carroll, MD January 14, 2015 International Comparison of Spending on Health, 1980 2010 Average spending on health
More informationE. Scafato C. Gandin, L. Galluzzo, S. Ghirini, S. Martire, R. Scipione Istituto Superiore di Sanità, Italy
Guidelines to support early identification and brief interventions for alcohol use disorders in Europe: overview of RARHA survey results and of other EU projects E. Scafato C. Gandin, L. Galluzzo, S. Ghirini,
More informationMaternal Mortality and HIV: Examining Research through a Programma;c Lens. Day 1 Recap
Maternal Mortality and HIV: Examining Research through a Programma;c Lens Day 1 Recap Introduc;on Every day, approximately 800 women die from preventable causes related to pregnancy and childbirth. 99%
More informationGlobal health; understanding, approach and major issues
Global health; understanding, approach and major issues Gabriel Gulis Unit of health promotion research Institute of public health, Faculty of medical sciences University of Southern Denmark Esbjerg, Denmark
More informationCare of Diabe+c Pa+ents in the Hospital Se6ng
Care of Diabe+c Pa+ents in the Hospital Se6ng 1/11/2011 Kathia Desronvil, BSN, MSN, FNP- BC Hospitalist, Internal Medicine Department Nash General Hospital Rocky Mount, NC 27616 (H) 919-890- 5561; (C)
More information1. ATHENA Network, AVAC, and Salamander Trust with UN Women, undertook this mul>-stage review of the global status of access to an>retroviral therapy
1. ATHENA Network, AVAC, and Salamander Trust with UN Women, undertook this mul>-stage review of the global status of access to an>retroviral therapy (ART) for women living with HIV 2. This is the first
More informationUnderstanding. Design & Sta/s/cs. in Clinical Trials
Understanding Design & Sta/s/cs in Clinical Trials 1 Why bother? 2 Experience- Based Medicine? Benjamin Rush Father of American Psychiatry 3 Experience- Based Medicine? Supported blood- lejng as treatment
More informationWebinar Series Its All About the Interac0on Strategies for Pragma2c Organiza2on of Communica2on Systems PART 1
Webinar Series Its All About the Interac0on Strategies for Pragma2c Organiza2on of Communica2on Systems PART 1 Presented by: Jane Goetz, Au2sm Coordinator & Lori Chambers, Regional Systems Coordinator
More informationSets, Logic, and Probability As Used in Decision Support Systems
Sets, Logic, and Probability As Used in Decision Support Systems HAP 752 Advanced Health Informa6on Systems Janusz Wojtusiak, PhD George Mason University Spring 2014 Part of the inhumanity of the computer
More informationFor Objec*ve Causal Inference, Design Trumps Analysis. Donald B. Rubin Department of Sta*s*cs Harvard University 16 March 2012
For Objec*ve Causal Inference, Design Trumps Analysis Donald B. Rubin Department of Sta*s*cs Harvard University 16 March 2012 1 Prologue to Objec*ve Causal Inference in Observa*onal Studies My Introduc*on
More informationProgram: Module 2: Diagnosis and Investigation of HF and Practical Case Studies Treatment of Heart Failure and Practical Case Studies
Program: Module 1: Definition and Classification Epidemiology of Heart Failure Pathophysiology of Heart Failure Specific Diseases causing Heart Failure and practical case studies Module 2: Diagnosis and
More informationShould Me*ormin be contraindicated in pa4ents with CKD? TAYLOR MCBRIDE UNIVERSITY OF TEXAS/HEB PGY-1 COMMUNITY PHARMACY RESIDENT
Should Me*ormin be contraindicated in pa4ents with CKD? TAYLOR MCBRIDE UNIVERSITY OF TEXAS/HEB 2018-2019 PGY-1 COMMUNITY PHARMACY RESIDENT 1 Objec4ves Understand the changes to Me*ormin labeled use in
More informationMaryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center
Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center at the Maritime Institute Pharmacy-Driven Inpatient
More informationThe Data- Rich, Information- Driven Future of Healthcare
The Data- Rich, Information- Driven Future of Healthcare William Hersh, MD Professor and Chair Department of Medical Informatics & Clinical Epidemiology Oregon Health & Science University Portland, OR,
More informationOhio Medical Marijuana Control Program
Ohio Medical Marijuana Control Program Guiding Principles Ohio Medical Marijuana Control Program is: 1. Pa;ent-centered and safe 2. Responsive, data-driven, and transparent 3. Flexible, scalable, and sustainable
More informationAppendix Identification of Study Cohorts
Appendix Identification of Study Cohorts Because the models were run with the 2010 SAS Packs from Centers for Medicare and Medicaid Services (CMS)/Yale, the eligibility criteria described in "2010 Measures
More informationThe Digital Age of HP2020
The Digital Age of HP2020 Theresa Devine, MPH Office of Disease Preven0on and Health Promo0on (HHS) Sarah Pomerantz, MPH CommunicateHealth, Inc. Ma5 Allen CommunicateHealth, Inc. This Morning s Agenda
More informationAre We Ready for ASAM? Does the ASAM Level of Care Designa:ons Correspond to Clinical Judgment?
Are We Ready for ASAM? Does the ASAM Level of Care Designa:ons Correspond to Clinical Judgment? Desirée A. Crevecoeur-MacPhail, PhD UCLA Integrated Substance Abuse Programs Semel Ins@tute for Neuroscience
More informationMedicare & Medicaid EHR Incentive Programs
Medicare & Medicaid EHR Incentive Programs Stage 2 NPRM Overview Robert Anthony March 6, 2012 Proposed Rule Everything discussed in this presentation is part of a notice of proposed rulemaking (NPRM).
More informationAgenda. Clinical and Operational Considerations for Appropriate Telepsychiatry Best Prac/ces for Designing and Implemen/ng Telebehavioral Health
Clinical and Operational Considerations for Appropriate Telepsychiatry Best Prac/ces for Designing and Implemen/ng Telebehavioral Health RCPA- Fall 2014 Geoffrey Boyce, MBA Execu/ve Director InSight James
More informationClinical Research Project Design and Guidelines: Choosing a Research Ques8on
Clinical Research Project Design and Guidelines: Choosing a Research Ques8on Odunayo M. Oluwatosin, FMCS (Nig) Department of Plas?c Surgery University College Hospital Ibadan 1 Learning outcome: by the
More informationInformation Technology-Driven Analytics: The Link Between Data Aggregation, Analytics and EHRs. Ronald A. Paulus, MD President and CEO June 27, 2011
Information Technology-Driven Analytics: The Link Between Data Aggregation, Analytics and EHRs Ronald A. Paulus, MD President and CEO June 27, 2011 1 Summary Analytics and EHRs are co-dependent and complementary
More informationTraining + U*lizing Student Staff as Ac*ve Bystanders
Training + U*lizing Student Staff as Ac*ve Bystanders Ka*e Sorokas Kent State University ksorokas@kent.edu Jennifer O Connell Kent State University joconne5@kent.edu Outline Descrip*on of Kent State University
More informationDiabetes Self- management Educa4on and Support (DSME/S)
Improving Patient Care Through Diabetes Self- management Education Davida F. Kruger, MSN, APN-BC, BC-ADM Certified Nurse Practitioner Henry Ford Health System Division of Endocrinology, Diabetes, Bone
More informationObjec0ves. Next Genera0on Biomarkers in Prostate Cancer. UBC Department of Urologic Sciences. Jennifer Locke, R2 January 28, 2015
UBC Department of Urologic Sciences Next Genera0on Biomarkers in Prostate Cancer Jennifer Locke, R2 January 28, 2015 Objec0ves 1. Highlight why biomarkers are important in prostate cancer management 2.
More informationSIMPATH Y. S*mula*ng Innova*on Management of Polypharmacy and Adherence in the Elderly Simpathy
S*mula*ng Innova*on Management of Sunfrail Transla1onal workshop Understanding and caring for frailty and mul1morbidity Bologna, March 22nd 2016 S*mula*ng Innova*on Management of Polypharmacy and Adherence
More informationRisk Assessment in IPC. Key Defini>ons. Risk Assessment in IPC
Dr Nizam Damani MSc, MBBS, FRCPath., FRCPI, CIC, DipHIC Associate Medical Director Infec>on Preven>on and Control Southern Health & Social Care Trust, Portadown, UK Senior Lecturer, Queen s University,
More informationStacie Fruth, PT, DHSc, OCS Michael Brickens, PT Tim Ellender, MD Jenny Gojmerac- Owens, NP Julie Welch, MD. Stacie Fruth, PT, DHSc, OCS
Physical Therapists on the Emergency Department Team: PT and MD Perspec8ves Stacie Fruth, PT, DHSc, OCS Michael Brickens, PT Tim Ellender, MD Jenny Gojmerac- Owens, NP Julie Welch, MD Combined Sec,ons
More informationPolypharmacy Reviews in the real world
S P S Community Health Services Specialist Pharmacy Service Medicines Use and Safety Polypharmacy Reviews in the real world Lelly Oboh Consultant Pharmacist, Care of Older People Guys & St Thomas NHS Founda@on
More informationDebate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza
Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza Aeron Hurt WHO Collabora@ng Centre for Reference and Research on Influenza, Melbourne, Australia www.influenzacentre.org NA inhibitor
More information